This document addresses insulin potentiation therapy (IPT): administration of insulin as an adjunctive agent to potentiate the effects of pharmacologic therapy in the treatment of cancer as well as infectious diseases, chronic degenerative disorders, fibromyalgia, chronic fatigue syndrome, arthritis, and many other conditions. The adjunctive use of insulin is believed to enhance the effect of chemotherapy by “opening up” the receptors on cancer cells to increase absorption of the pharmacological agent or chemotherapy, thereby lowering the effective chemotherapy dose.

Position Statement

Investigational and Not Medically Necessary:

Insulin potentiation therapy (IPT) is considered investigational and not medically necessary for the treatment of cancer, infectious diseases, chronic degenerative disorders, and all other conditions.